Application of Al18F-octreotide PET/CT in Neuroendocrine Tumor
- First Posted Date
- 2023-03-01
- Last Posted Date
- 2024-03-29
- Target Recruit Count
- 400
- Registration Number
- NCT05749289
- Locations
- 🇨🇳
National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Chao Yang, China
Oral Vinorelbine and Capecitabine in Advanced HER2-negative Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- Drug: oral vinorelbine and capecitabine
- First Posted Date
- 2023-02-28
- Last Posted Date
- 2023-02-28
- Target Recruit Count
- 30
- Registration Number
- NCT05747326
- Locations
- 🇨🇳
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Beijing, Beijing, China
Chidamide in Combination With Vincristine Metronomic Chemotherapy for Advanced Triple-negative Breast Cancer
- First Posted Date
- 2023-02-28
- Last Posted Date
- 2023-02-28
- Target Recruit Count
- 40
- Registration Number
- NCT05747313
- Locations
- 🇨🇳
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Beijing, Beijing, China
Fluorescence Laparoscopic Navigation for Rectal Cancer and Sigmoid Colon Cancer
- Conditions
- Colorectal NeoplasmsFluorescenceLymph Node Excision
- Interventions
- Procedure: lymph node dissection
- First Posted Date
- 2023-02-16
- Last Posted Date
- 2023-08-29
- Target Recruit Count
- 550
- Registration Number
- NCT05730595
- Locations
- 🇨🇳
The First Affiliated Hospital of Chengdu Medical College, Chengdu, Chengdu, China
🇨🇳Binzhou Medical University, Binzhou, Shandong, China
🇨🇳The First Affiliated Hospital of University of Science and Technology of China, Hefei, Anhui, China
Multivisceral Radical Resection for Surgical T4b Colorectal Cancer: Propensity Score-matched Study Comparing the the Laparoscopic and Open Approaches
- Conditions
- Colorectal Cancer
- Interventions
- Procedure: Laparoscopic surgery
- First Posted Date
- 2023-02-01
- Last Posted Date
- 2024-12-27
- Target Recruit Count
- 638
- Registration Number
- NCT05707598
- Locations
- 🇨🇳
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing, China
A Phase II Study Evaluating the Efficacy and Safety of Pembrolizumab in Combination With Chemotherapy as Neoadjuvant Therapy for Triple-negative Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2023-01-12
- Last Posted Date
- 2023-01-12
- Target Recruit Count
- 26
- Registration Number
- NCT05681728
- Locations
- 🇨🇳
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China
The Influence of Treatment Position (Prone vs. Supine) on Whole Breast Target
- Conditions
- Breast Cancer
- Interventions
- Device: dedicated treatment board with no degree
- First Posted Date
- 2022-11-08
- Last Posted Date
- 2023-01-31
- Target Recruit Count
- 300
- Registration Number
- NCT05609058
- Locations
- 🇨🇳
Shanxi provicial cancer hospital, Taiyuan, Shanxi, China
Deep Learning-based Classification and Prediction of Radiation Dermatitis in Head and Neck Patients
- Conditions
- Head and Neck CancerRadiation Dermatitis
- First Posted Date
- 2022-11-07
- Last Posted Date
- 2022-11-07
- Target Recruit Count
- 300
- Registration Number
- NCT05607225
- Locations
- 🇨🇳
Shenzhen Cancer Hospital, Chinese Academy of Medical Sciences, Shenzhen, Guangdong, China
🇨🇳Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
A Prospective Study of Preoperative Tumor-bed Boost Followed by Oncoplastic Surgery and Adjuvant Whole Breast Radiotherapy for Early Stage Breast Cancer (BIRKIN)
- Conditions
- Breast Neoplasms
- Interventions
- Radiation: Preoperative MRI-guided tumor-bed boost and postopreative ultra-hypofractionated radiotherapy (26 Gy/5.2Gy/5)
- First Posted Date
- 2022-11-02
- Last Posted Date
- 2022-11-02
- Target Recruit Count
- 102
- Registration Number
- NCT05603078
- Locations
- 🇨🇳
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China
Early Screening of Colorectal Cancer Based on Plasma Multi-omics Combining With Artificial Intelligence
- Conditions
- Colorectal CancerColorectal Adenoma
- Interventions
- Diagnostic Test: ColonoscopyDiagnostic Test: Test of ctDNA methylationDiagnostic Test: Test of characteristics of ctDNA fragment
- First Posted Date
- 2022-10-20
- Last Posted Date
- 2022-10-24
- Target Recruit Count
- 950
- Registration Number
- NCT05587452
- Locations
- 🇨🇳
Heji Hospital affiliated to Changzhi Medical College, Changzhi, Shanxi, China
🇨🇳Affiliated Hospital of Weifang Medical University, Weifang, Shandong, China
🇨🇳Beiijing Fengtai Hospital, Beijing, Beijing, China